98%
921
2 minutes
20
Background: Radiologic emphysema is increasingly observed in patients with asthma, yet its prognostic significance remains unclear. This study aimed to evaluate whether emphysema identified on chest computed tomography (CT) predicts accelerated lung function decline among asthma patients.
Methods: We conducted a retrospective cohort study of adult asthma patients who received inhaled corticosteroid therapy and underwent serial pulmonary function tests over a minimum follow-up of one year at two tertiary hospitals. Radiologic emphysema was identified via visual CT assessment, and patients were stratified into emphysema and non-emphysema groups. Annual changes in forced expiratory volume in 1 s (FEV) and FEV/forced vital capacity ratio (FVC) were analysed using multivariable linear mixed-effects models. Sensitivity analyses assessed rapid lung function decline using multivariable logistic regression.
Findings: Of 351 patients included, 117 (33.3 %) had radiologic emphysema. The emphysema group showed significantly greater annual declines in FEV (-38.7 vs. -7.8 mL/year) and FEV/FVC (-0.62 %/year vs. 0 %/year). Emphysema was independently associated with accelerated decline in both parameters after full adjustment (FEV: β = -12.5 mL/year, 95 % CI: -18.9 to -6.2; FEV/FVC: β = -0.31 %/year, 95 % CI: -0.47 to -0.15; both P < 0.001). Sensitivity analyses confirmed increased odds of rapid decline (adjusted OR for FEV: 2.232; FEV/FVC: 2.231).
Interpretation: Radiologic emphysema defines a distinct asthma phenotype associated with progressive airflow limitation. Integrating structural imaging into routine asthma assessment may enhance risk stratification and guide individualized management.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.rmed.2025.108261 | DOI Listing |
Radiology
September 2025
Department of Electrical, Electronic, and Information Engineering "Guglielmo Marconi", University of Bologna, Cesena, Italy.
Radiology
September 2025
Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Plc, Box 1234, New York, NY 10029.
Background The prognostic value of baseline visual emphysema scoring at low-dose CT (LDCT) in lung cancer screening cohorts is unknown. Purpose To determine whether a single visual emphysema score at LDCT is predictive of 25-year mortality from all causes, chronic obstructive pulmonary disease (COPD), and cardiovascular disease (CVD). Materials and Methods In this prospective cohort study, asymptomatic adults aged 40-85 years with a history of smoking underwent baseline LDCT screening for lung cancer between June 2000 and December 2008.
View Article and Find Full Text PDFJ Thorac Oncol
September 2025
Department of Radiology, Seoul National University Hospital and Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea. Electronic address:
Introduction: Interval lung cancers (ILCs) are key indicators of lung cancer screening (LCS) performance. However, data on the proportion, characteristics, and mortality of ILCs under biennial screening in Asian populations remain limited.
Methods: We analyzed participants from the baseline biennial Korean national LCS program between 2019 and 2020.
J Magn Reson Imaging
September 2025
Department of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Background: Radiation-free four-dimensional (4D) dynamic ultrashort echo time MRI (UTE MRI) enables quantification of ventilation defects in chronic obstructive pulmonary disease (COPD) and preserved ratio impaired spirometry (PRISm) populations.
Purpose: To quantify pulmonary ventilation using 4D UTE MRI in PRISm and COPD populations, and determine its ability to distinguish PRISm from non-COPD subjects.
Study Type: Prospective, cross-sectional.
NPJ Digit Med
August 2025
Applied Chest Imaging Laboratory, Department of Radiology and Medicine, Brigham and Women's Hospital, Harvard Medical School, 399 Revolution Drive, Somerville, 02145, MA, USA.
Emphysema progression in chronic obstructive pulmonary disease (COPD) presents a notable challenge due to its significant variability among individuals and the current lack of reliable prognostic markers. Given the limited therapeutic options available for emphysema, there is a critical need for early detection and intervention strategies. Identifying individuals at risk of rapid progression is essential to effectively halt or slow the disease's advancement.
View Article and Find Full Text PDF